215 related articles for article (PubMed ID: 14669793)
1. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Davidson B; Givant-Horwitz V; Lazarovici P; Risberg B; Nesland JM; Trope CG; Schaefer E; Reich R
Clin Exp Metastasis; 2003; 20(7):621-31. PubMed ID: 14669793
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions.
Givant-Horwitz V; Davidson B; Lazarovici P; Schaefer E; Nesland JM; Tropé CG; Reich R
Gynecol Oncol; 2003 Oct; 91(1):160-72. PubMed ID: 14529677
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38.
Lim M; Martinez T; Jablons D; Cameron R; Guo H; Toole B; Li JD; Basbaum C
FEBS Lett; 1998 Dec; 441(1):88-92. PubMed ID: 9877171
[TBL] [Abstract][Full Text] [Related]
5. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
6. Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages.
Wang Y; Huang ZQ; Wang CQ; Wang LS; Meng S; Zhang YC; Chen T; Fan YQ
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):11-8. PubMed ID: 21039753
[TBL] [Abstract][Full Text] [Related]
7. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.
Tomita T; Nakase T; Kaneko M; Shi K; Takahi K; Ochi T; Yoshikawa H
Arthritis Rheum; 2002 Feb; 46(2):373-8. PubMed ID: 11840439
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.
Yang JM; Xu Z; Wu H; Zhu H; Wu X; Hait WN
Mol Cancer Res; 2003 Apr; 1(6):420-7. PubMed ID: 12692261
[TBL] [Abstract][Full Text] [Related]
9. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
11. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678
[TBL] [Abstract][Full Text] [Related]
12. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
13. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
[TBL] [Abstract][Full Text] [Related]
14. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
15. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
Davidson B; Konstantinovsky S; Kleinberg L; Nguyen MT; Bassarova A; Kvalheim G; Nesland JM; Reich R
Gynecol Oncol; 2006 Sep; 102(3):453-61. PubMed ID: 16494928
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
Davidson B; Reich R; Berner A; Givant-Horwitz V; Goldberg I; Risberg B; Kristensen GB; Trope CG; Bryne M; Kopolovic J; Nesland JM
Eur J Cancer; 2001 Nov; 37(16):2040-9. PubMed ID: 11597382
[TBL] [Abstract][Full Text] [Related]
18. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers.
Norgauer J; Hildenbrand T; Idzko M; Panther E; Bandemir E; Hartmann M; Vanscheidt W; Herouy Y
Br J Dermatol; 2002 Dec; 147(6):1180-6. PubMed ID: 12452868
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]